AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Total Assets · Q3 FY2025 · quarter ended Sep 2025
Total assets of €165.63M in Q3 FY2025
Q3 FY2025 total assets was €165.63M.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
Currency unavailable · from the balance sheet
No Total Assets data reported for this period type.
Total Assets vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $560.62M USD | -8.2% | +56.2% |
| Mar 2026 | $329.68M USD | -21.9% | -15.8% | |
| Mar 2026 | $198.72M USD | +0.3% | -14.3% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €165.63M EUR | — | — |
| Mar 2026 | $63.08M USD | +277.1% | -25.9% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
| Peer median (excluding AGMB) | — | -4.0% | -15.0% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.